COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04590326
Brief Title: Study of REGN5668 Administered in Combination With Cemiplimab or REGN4018 in Adult Women With Recurrent Ovarian Cancer.

First Submitted : October 9, 2020
First Submitted that Met QC Criteria : October 9, 2020
First Posted : October 19, 2020

Last Update Submitted that Met QC Criteria : January 21, 2021
Last Update Posted : January 22, 2021